The cure rate of leukemia type M4Eo is related to the patient’s physical condition, disease progression, intensity of treatment, etc., and its cure rate cannot be generalized.
Leukemia m4eo, acute granulocyte-monocyte leukemia, is a kind of acute leukemia due to the simultaneous malignant proliferation of both granulocyte and monocyte lineages. Clinical features of both acute granulocytic leukemia and acute monocytic leukemia, often accompanied by liver, spleen, lymph node enlargement and other clinical manifestations.
Leukemia m4eo belongs to the low-risk type, mainly to chemotherapy, through the standard dose of chemotherapy cure rate is relatively high, the prognosis is good, and in most cases can achieve the long-term survival of the therapeutic objectives. However, some patients are prone to more serious complications after chemotherapy, resulting in the intensity of chemotherapy can not keep up, even if the low-risk type can not achieve a better cure rate.
Generally speaking, the five-year survival rate of leukemia m4eo type is low. The five-year survival rate is even lower if the patient is elderly and has underlying diseases, such as heart disease and high blood pressure.
If leukemia m4eo is diagnosed, early and standardized treatment is recommended to reduce the adverse effects of the disease.